INTERESTED IN THIS RESEARCH?
Contact our analysts for inquiries, samples, and expert insights.
REPORT OUTLOOK
| Market Size | CAGR | Dominating Region |
|---|---|---|
| USD 14.61 billion | 6.1% | North America |
| By Offering | By Technology | By Functionality |
|---|---|---|
|
|
 |
SCOPE OF THE REPORT
Artificial Intelligence In Genomics Market Overview
The global artificial intelligence in genomics market is projected to reach USD 14.61 billion by 2029 from USD 8.34 billion in 2022, at a CAGR of 6.1% from 2023 to 2029.
Genomics is a branch of science that studies genes and their functions, as well as the structure, evolution, and mapping of genomes in living organisms. The genetic test is used to learn about illness susceptibility, treatment response, and human biology in general. The study of genomics includes structural and functional studies, DNA sequencing, and bioinformatics to sequence, and recombinant DNA. The application of artificial intelligence (AI) in genomics focuses on the creation of computer systems that can conduct tasks like genome mapping. The structure, evolution, and function of genetic material can be studied more quickly with AI than with human interaction. Although AI algorithms are designed to simulate human intelligence, they are also utilised in clinical genomics to undertake genomic analysis such as genome annotation, variant calling, phenotype-to-genotype correspondence, and genome annotation.
In addition, AI approaches can aid in the accurate prediction of protein structure or DNA data with minimal feature handcrafting. Genomic medicine has a crucial role to play in customized medicine. In this field, AI can help in the production of drugs.
| ATTRIBUTE | DETAILS |
| Study period | 2022-2029 |
| Base year | 2022 |
| Estimated year | 2023 |
| Forecasted year | 2023-2029 |
| Historical period | 2018-2022 |
| Unit | Value (USD Billion) |
| Segmentation | By Offering, By Technology, By Functionality, By Region. |
| By Offering
 |
|
| By Technology
 |
|
| By Functionality
 |
 |
| By Region
 |
|
The necessity to keep medication development and discovery costs and timelines under control is propelling the artificial intelligence in genomics market forward. The global artificial intelligence in genomics market is expected to grow during the projected period as the demand to control discovery costs and time during new drug development grows. Drug development is a time-consuming, complicated, and costly process that necessitates the application of several technologies in the quest for novel medications. In drug discovery and development, in vivo and in vitro techniques, which are both costly and time-consuming, are widely used. Artificial intelligence is playing an increasingly important role in drug discovery, with the potential to save a significant amount of time and money. As a result, throughout the forecast period, the market is expected to grow. The market is growing as a result of increased public and private investments in AI in genomics. This market’s growth is being fueled by the deployment of AI technologies in precision medicine.
However, during the forecast period, the lack of a competent AI workforce and uncertain regulatory rules for medical software are expected to limit the artificial intelligence in genomics market’s growth. Furthermore, in recent years, a number of countries have made major investments in genomics research. This is a market with a lot of room for expansion. These expenditures have substantially benefited the development of new technology. The Department of Biotechnology, for example, launched the Genome India Project (GIP) (DBT). The purpose of this study is to collect 10,000 genetic samples from Native Americans.
Artificial Intelligence In Genomics Market Segment Analysis
The artificial intelligence in genomics market is divided into software, services based on offering. AI can take the form of software or tools that can resemble human intelligence in some situations and even outperform it in others. As the complexity of genetic data grows, researchers are turning to artificial intelligence and machine learning to uncover important correlations.
The market is divided into machine learning, computer vision based on technology. Pharmaceutical corporations, contract research organisations, and biotechnology companies all used machine learning for drug genomics applications, which dominated the market. This is due to machine learning’s ability to extract insights from enormous data sets, hence speeding up genomic research.
The market is divided into genome sequencing, gene editing, gene mapping based on functionality. Traditional operations and medications are anticipated to be replaced as gene therapy advances. Healthcare providers will be able to treat an illness by putting a gene into their patients’ cells. The discovery of gene editing is both delicate and strong.
Artificial Intelligence In Genomics Market Players
The major players operating in the global artificial intelligence in genomics industry include IBM, Microsoft, NVIDIA Corporation, Deep Genomics, BenevolentAI, Fabric Genomics Inc., Verge Genomics, Freenome Holdings, Inc., MolecularMatch Inc., and Cambridge Cancer Genomics. The presence of established industry players and is characterized by mergers and acquisitions, joint ventures, capacity expansions, substantial distribution, and branding decisions to improve market share and regional presence. Also, they are involved in continuous R&D activities to develop new products as well as are focused on expanding the product portfolio. This is expected to intensify competition and pose a potential threat to the new players entering the market.
21 March, 2022 IBM and Genomics England Forge New Partnership to Transform Patient Care
Genomics, the study of how your genes interact with the external world, is transforming how medical science works. England is leading the world in using this information in the healthcare system, enabling clinicians to bring these insights to determine the treatment for a particular patient – this is precision medicine. Understanding genomes can provide evidence to help diagnose disease more quickly and specifically, particularly in cancer and rare diseases. This understanding of disease is important to researchers working to develop new diagnostic tests and treatments – small changes in a genome can show how to target treatments to help more patients in future.
In February 2020, IBM Watson Health signed partnership with Broad Institute of MIT and Harvard (US). An extended partnership will allow the Broad Institute to analyze and explore genomics data to understand intrinsic susceptibility.
In October 2020, NVIDIA announced a partnership with global healthcare company GSK and its AI group. GSK’s new hub in London is expected to support its UK based team and scientists from NVIDIA to enhance drug and vaccine discovery using NVIDIA platforms.
Who Should Buy? Or Key stakeholders
- Research and development
- Manufacturing
- End Use industries
- Healthcare sector
- Specialty Clinic
Artificial Intelligence In Genomics Market Regional Analysis
Geographically, the artificial intelligence in genomics market is segmented into North America, South America, Europe, APAC and MEA.
- North America: includes the US, Canada, Mexico
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
- South America: includes Brazil, Argentina and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
North America is expected to hold the largest share of the global artificial intelligence in genomics.  Due to the increased acceptance of AI in genome sequencing and rising awareness among regional pharma and biotech organisations, the AI in genomics market in North America is expected to rise. In North America, AI deep learning algorithms have also saved countless lives by lowering the time it takes to diagnose diseases patients’ treatment recovery cycle. The implementation of personal genome sequencing testing, particularly for reproductive health, is being driven by growing awareness among European patients. Artificial Intelligence (AI) is widely used in diagnostics and contributes to more accessible, economical, and high-quality healthcare, resulting in increased accuracy.
Key Market Segments: Artificial Intelligence In Genomics Market
Artificial Intelligence In Genomics Market By Offering, 2022-2029, (USD Million)
- Software
- Services
Artificial Intelligence In Genomics Market By Technology, 2022-2029, (USD Million)
- Machine Learning
- Computer Vision
Artificial Intelligence In Genomics Market By Functionality, 2022-2029, (USD Million)
- Genome Sequencing
- Gene Editing
- Gene Mapping
Artificial Intelligence In Genomics Market By Regions, 2022-2029, (USD Million)
- North America
- Europe
- Asia Pacific
- South America
- Middle East and Africa
Important Countries in All Regions Are Covered.
Key Question Answered
- What is the current scenario of global artificial intelligence in genomics market?
- What are the emerging technologies for the development of artificial intelligence in genomics devices?
- What are the historical size and the present size of the market segments and their future potential?
- What are the major catalysts for the market and their impact during the short, medium, and long terms?
- What are the evolving opportunities for the players in the market?
- Which are the key regions from the investment perspective?
- What are the key strategies being adopted by the major players to up their market shares?
Table of Content
- INTRODUCTION
- MARKET DEFINITION
- MARKET SEGMENTATION
- RESEARCH TIMELINES
- ASSUMPTIONS AND LIMITATIONS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT-MATTER EXPERTS’ ADVICE
- QUALITY CHECKS
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- DATA SOURCES
- DATA MINING
- EXECUTIVE SUMMARY
- MARKET OVERVIEW
- GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET OUTLOOK
- MARKET DRIVERS
- MARKET RESTRAINTS
- MARKET OPPORTUNITIES
- IMPACT OF COVID-19 ON ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET
- PORTER’S FIVE FORCES MODEL
- THREAT FROM NEW ENTRANTS
- THREAT FROM SUBSTITUTES
- BARGAINING POWER OF SUPPLIERS
- BARGAINING POWER OF CUSTOMERS
- DEGREE OF COMPETITION
- INDUSTRY VALUE CHAIN ANALYSIS
- GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET OUTLOOK
- GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLION)
- SOFTWARE
- SERVICES
- GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLION)
- MACHINE LEARNING
- COMPUTER VISION
- GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLION)
- GENOME SEQUENCING
- GENE EDITING
- GENE MAPPING
- GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY REGION
- NORTH AMERICA
- US
- CANADA
- MEXICO
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- COLOMBIA
- REST OF SOUTH AMERICA
- EUROPE
- GERMANY
- UK
- FRANCE
- ITALY
- SPAIN
- RUSSIA
- REST OF EUROPE
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- SOUTH-EAST ASIA
- REST OF ASIA PACIFIC
- MIDDLE EAST AND AFRICA
- UAE
- SAUDI ARABIA
- SOUTH AFRICA
- REST OF MIDDLE EAST AND AFRICA
- NORTH AMERICA
- COMPANY PROFILES* (BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)
- IBM
- MICROSOFT
- NVIDIA CORPORATION
- DEEP GENOMICS
- BENEVOLENTAI
- FABRIC GENOMICS INC
- VERGE GENOMICS
- FREENOME HOLDINGS, INC.
- MOLECULARMATCH INC
- CAMBRIDGE CANCER GENOMICS *THE COMPANY LIST IS INDICATIVE
LIST OF TABLES
TABLE 1Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLIONS)
TABLE 2Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLIONS) 2022-2029
TABLE 3Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLIONS) 2022-2029
TABLE 4Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY REGION (USD MILLIONS) 2022-2029
TABLE 5Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLIONS) 2022-2029
TABLE 6Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLIONS) 2022-2029
TABLE 7Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLIONS) 2022-2029
TABLE 8Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLIONS) 2022-2029
TABLE 9Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLIONS) 2022-2029
TABLE 10Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLIONS) 2022-2029
TABLE 11Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLIONS) 2022-2029
TABLE 12Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLIONS) 2022-2029
TABLE 13Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLIONS) 2022-2029
TABLE 14Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLIONS) 2022-2029
TABLE 15Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLIONS) 2022-2029
TABLE 16Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLIONS) 2022-2029
TABLE 17Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLIONS) 2022-2029
TABLE 18Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLIONS) 2022-2029
TABLE 19Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLIONS) 2022-2029
TABLE 20Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLIONS) 2022-2029
TABLE 21Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLIONS) 2022-2029
TABLE 22Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLIONS) 2022-2029
TABLE 23Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLIONS) 2022-2029
TABLE 24Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLIONS) 2022-2029
TABLE 25Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLIONS) 2022-2029
TABLE 26Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLIONS) 2022-2029
TABLE 27Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLIONS) 2022-2029
TABLE 28Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLIONS) 2022-2029
TABLE 29Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLIONS) 2022-2029
TABLE 30Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLIONS) 2022-2029
TABLE 31Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLIONS) 2022-2029
TABLE 32Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLIONS) 2022-2029
TABLE 33Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLIONS) 2022-2029
TABLE 34Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLIONS) 2022-2029
TABLE 35Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLIONS) 2022-2029
TABLE 36Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLIONS) 2022-2029
TABLE 37Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLIONS) 2022-2029
TABLE 38Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLIONS) 2022-2029
TABLE 39Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLIONS) 2022-2029
TABLE 40Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLIONS) 2022-2029
TABLE 41Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLIONS) 2022-2029
TABLE 42Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLIONS) 2022-2029
TABLE 43Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLIONS) 2022-2029
TABLE 44Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLIONS) 2022-2029
TABLE 45Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLIONS) 2022-2029
TABLE 46Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLIONS) 2022-2029
TABLE 47Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLIONS) 2022-2029
TABLE 48Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLIONS) 2022-2029
TABLE 49Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLIONS) 2022-2029
TABLE 50Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â UK ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLIONS) 2022-2029
TABLE 51Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â UK ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLIONS) 2022-2029
TABLE 52Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â UK ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLIONS) 2022-2029
TABLE 53Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLIONS) 2022-2029
TABLE 54Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLIONS) 2022-2029
TABLE 55Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLIONS) 2022-2029
TABLE 56Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLIONS) 2022-2029
TABLE 57Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLIONS) 2022-2029
TABLE 58Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLIONS) 2022-2029
TABLE 59Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLIONS) 2022-2029
TABLE 60Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLIONS) 2022-2029
TABLE 61Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLIONS) 2022-2029
TABLE 62Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLIONS) 2022-2029
TABLE 63Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLIONS) 2022-2029
TABLE 64Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLIONS) 2022-2029
TABLE 65Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLIONS) 2022-2029
TABLE 66Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLIONS) 2022-2029
TABLE 67Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLIONS) 2022-2029
TABLE 68Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â UAE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLIONS) 2022-2029
TABLE 69Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â UAE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLIONS) 2022-2029
TABLE 70Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â UAE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLIONS) 2022-2029
TABLE 71Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLIONS) 2022-2029
TABLE 72Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLIONS) 2022-2029
TABLE 73Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLIONS) 2022-2029
TABLE 74Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLIONS) 2022-2029
TABLE 75Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLIONS) 2022-2029
TABLE 76Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLIONS) 2022-2029
TABLE 77Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING (USD MILLIONS) 2022-2029
TABLE 78Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNOLOGY (USD MILLIONS) 2022-2029
TABLE 79Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY FUNCTIONALITY (USD MILLIONS) 2022-2029
LIST OF FIGURES
FIGURE 1Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â MARKET DYNAMICS
FIGURE 2Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â MARKET SEGMENTATION
FIGURE 3Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â DATA TRIANGULATION
FIGURE 5Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â BOTTOM-UP APPROACH
FIGURE 6Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â TOP-DOWN APPROACH
FIGURE 7Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â RESEARCH FLOW
FIGURE 8Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY OFFERING, USD MILLION, 2022-2029
FIGURE 9Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY TECHNIQUE, USD MILLION, 2022-2029
FIGURE 10Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY END USER, USD MILLION, 2022-2029
FIGURE 11Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET BY REGION, USD MILLION, 2022-2029
FIGURE 12             PORTER’S FIVE FORCES MODEL
FIGURE 13Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SNAPSHOT
FIGURE 14Â Â Â Â Â Â Â Â Â Â Â Â Â EUROPE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SNAPSHOT
FIGURE 15Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SNAPSHOT
FIGURE 16Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SNAPSHOT
FIGURE 17Â Â Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SNAPSHOT
FIGURE 18Â Â Â Â Â Â Â Â Â Â Â Â Â MARKET SHARE ANALYSIS
FIGURE 19Â Â Â Â Â Â Â Â Â Â Â Â Â IBM: COMPANY SNAPSHOT
FIGURE 20Â Â Â Â Â Â Â Â Â Â Â Â Â MICROSOFT: COMPANY SNAPSHOT
FIGURE 21Â Â Â Â Â Â Â Â Â Â Â Â Â NVIDIA CORPORATION: COMPANY SNAPSHOT
FIGURE 22Â Â Â Â Â Â Â Â Â Â Â Â Â DEEP GENOMICS: COMPANY SNAPSHOT
FIGURE 23Â Â Â Â Â Â Â Â Â Â Â Â Â BENEVOLENTAI: COMPANY SNAPSHOT
FIGURE 24Â Â Â Â Â Â Â Â Â Â Â Â Â FABRIC GENOMICS INC: COMPANY SNAPSHOT
FIGURE 25Â Â Â Â Â Â Â Â Â Â Â Â Â VERGE GENOMICS: COMPANY SNAPSHOT
FIGURE 26Â Â Â Â Â Â Â Â Â Â Â Â Â MOLECULARMATCH INC: COMPANY SNAPSHOT
FIGURE 27Â Â Â Â Â Â Â Â Â Â Â Â Â FREENOME HOLDINGS, INC.: COMPANY SNAPSHOT
FAQ
The artificial intelligence in genomics market size had crossed USD 8.34 Billion in 2022 and will observe a CAGR of more than 6.1% up to 2029 driven by the burgeoning need to reduce the cost and time of drug development.
The upcoming trend in artificial intelligence in genomics market is focus on developing human-aware AI systems is an opportunity for market growth.
The global artificial intelligence in genomics market registered a CAGR of 6.1% from 2023 to 2029. The technology segment was the highest revenue contributor to the market.
North America is the largest regional market with 46% of share Due to the increased acceptance of AI in genome sequencing and rising awareness among regional pharma and biotech organisations, the AI in genomics market in North America is expected to rise.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.